BIOWIRE2K FOSTER CITY, Calif.–Sept. 5, 2006–Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced that it has entered into a settlement agreement with Promega Corporation resolving outstanding legal disputes between the two companies. The terms of the settlement were not disclosed.
Laval, QC, August 11, 2006 – Warnex Inc. (TSX: WNX) today announced that it has formed a strategic alliance with Eppendorf, a global leader in the laboratory equipment market, which will combine Eppendorf’s state-of-the-art Mastercycler® ep realplex real-time PCR system with Warnex’s pathogen detection kits and software to provide enhanced food safety tests. “In addition […]
Applied Biosystems (NYSE: ABI), an Applera Corporation business,announced that the U.S. Department of Defense has awarded the company a $24.5 million contract to accelerate the development of a prototype instrument system that is intended to improve the way infectious diseases are identified for epidemiological and biosecurity purposes. Upon successful completion of this project, this new […]
Shiga, Japan: La Jolla, CA-Takara Bio and Stratagene have settled their patent disputes regarding enzyme blends used in PCR technology. Financial details were unavailable. “We believe that there are a number of competitors selling products that are covered under our patent portfolio. It is our intention to make limited licenses available and recognize resulting licensing […]
Shiga, Japan,: La Jolla, CA-Takara Bioand Stratagene have settled their patent disputes regarding enzyme blendsused in PCR technology. Financial details were unavailable. “We believe that there are a number of competitors selling products that are covered under our patent portfolio. It is our intention to make limited licenses available and recognize resulting licensing revenue,” stated […]
Franklin Lakes, NJ-BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has signed an agreement to acquire GeneOhm Sciences, Inc., a privately held company headquartered in San Diego, California that has pioneered the development of molecular diagnostic testing for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs). GeneOhm […]
Venlo , The Netherlands and Hamburg , Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) and Eppendorf AG today announced that they have formed a strategic alliance that includes co-development and co-marketing of complementary and optimized products. The alliance is intended to link two of the strongest brands and product lines in […]
Venlo , The Netherlands and Foster City , CA – – QIAGEN N.V.Frankfurt , Prime Standard: QIA) and Applied Biosystems Group an Applera Corporation business announced that they have entered into a license agreement. Under the terms of the agreement, Applied Biosystems has granted a license to QIAGEN under the expanded Applied Biosystems PCR (polymerase […]
Thermo Electron Corporation has announced the purchase and installation of 215 additional MBS Satellite thermal cyclers at the Broad Institute of MIT and Harvard. The recent purchase brings the total number of units to 430, making the MBS Satellite thermal cycler the Broad Institute’s standard tool for large-scale genome sequencing and analysis. The Broad Institute […]
Pay Invoice
Latest Blogs
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
